Naftali Bennett joins board of Israeli biotech co
Former Israeli Prime Minister Naftali Bennett has joined the board of Remepy, which is pioneering hybrid drugs that include therapeutic applications that enhance the drug effect.
Stay updated with breaking news from Quantum Source. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Former Israeli Prime Minister Naftali Bennett has joined the board of Remepy, which is pioneering hybrid drugs that include therapeutic applications that enhance the drug effect.
This is the second tech company board that the former prime minister has joined since leaving politics.
Indigo Diabetes NV, a developer of a continuous metabolite monitoring device for people living with chronic diseases, named Arun Venkatasubramanian CT
Naftali Bennett's new job on the board of Israeli startup Quantum Source puts him on the front line in the West's battle with China for cyber supremacy.
Two companies to combine HPC infrastructure with room temperature photonic quantum technology